Drug Shortage Report for MAVIK
Report ID | 38488 |
Drug Identification Number | 02239267 |
Brand name | MAVIK |
Common or Proper name | MAVIK |
Company Name | BGP PHARMA ULC |
Market Status | MARKETED |
Active Ingredient(s) | TRANDOLAPRIL |
Strength(s) | 4MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C09AA |
ATC description | ACE INHIBITORS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-06-21 |
Actual start date | 2018-06-21 |
Estimated end date | 2018-07-06 |
Actual end date | 2018-06-27 |
Shortage status | Resolved |
Updated date | 2018-06-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.